Skip to main content
SpringerLink
Log in

Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

OBJECTIVE: To quantify medical care costs for the diagnosis and treatment of gastrointestinal disorders attributable to use of nonsteroidal anti-inflammatory drugs (NSAIDs) other than aspirin in elderly persons.

DESIGN AND SETTING: Retrospective cohort study of 75,350 Tennessee Medicaid enrollees at least 65 years of age.

MEASUREMENTS: The cohort was classified by baseline NSAID use as nonusers (no use preceding 1988), occasional users (⩾75% of days) or regular users (<75% of days). For the follow-up year (1989), we calculated annual rates of utilization of and Medicare/Medicaid payments for: medical care for NSAID-associated gastrointestinal disorders; hospitalizations/emergency department visits for peptic ulcers, gastritis/duodenitis, and gastrointestinal bleeding; outpatient upper and lower gastrointestinal tract radiologic and endoscopic examinations; and histamine2 (H2)-receptor antagonist, sucralfate, and antacid prescriptions. Rates were adjusted for demographic characteristics and baseline health care utilization.

RESULTS: Among nonusers of NSAIDs, the adjusted mean annual payment for all types of medical care for study gastrointestinal disorders was $134. This increased to $180 among occasional users, an excess of $46 (p<.001); and to $244 among regular users, an excess of $111 (p<.001, comparison with both nonusers and occasional users). Cohort members with any baseline year NSAID use had an adjusted mean annual payment of $191, $57 (p<.001) higher than that for nonusers. In both users and nonusers of NSAIDs, medications and inpatient care accounted for the largest component of costs. Among regular NSAID users, excess payments increased with baseline NSAID dose: $56, $120, and $157 for less than 1, 1 to 2, and more than 2 standard units per day, respectively (p<.01, linear trend).

CONCLUSIONS: Nonsteroidal anti-inflammatory drug (NSAID) use in elderly patients was associated with substantial excess costs and utilization of medical care for gastrointestinal disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Griffin MR. Piper JM. Daugherty JR. Snowden M. Ray WA. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114:257–63.

    PubMed  CAS  Google Scholar 

  2. Somerville K, Faulkner G. Langmen M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986;1:462–4.

    Article  PubMed  CAS  Google Scholar 

  3. Chrischilles EA, Lemke JH, Wallace RB, Drube GA. Prevalence and characteristics of multiple analgesic drug use in an elderly study group. J Am Geriatr Soc. 1990;38:979–84.

    PubMed  CAS  Google Scholar 

  4. Soil AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med. 1991;114:307–19.

    Google Scholar 

  5. Allison MC, Howaston AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1992;327:749–54.

    Article  PubMed  CAS  Google Scholar 

  6. Larkai EN. Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritis patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol. 1987;82:1153–8.

    PubMed  CAS  Google Scholar 

  7. Graham DY, White RH, Moreland LW. et al. Duodenal and gastric ulcer presention with misoprostol in arthritic patients taking NSAIDs. Ann Intern Med. 1993;119:257–62.

    PubMed  CAS  Google Scholar 

  8. Silvoso GR, Ivey KJ, Butt JH, et al. Incidence of gastric lesions in patients with rheumatic diseases on chronic aspirin therapy. Ann Intern Med. 1979;91:517–20.

    PubMed  CAS  Google Scholar 

  9. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988;2:1277–80.

    Article  PubMed  CAS  Google Scholar 

  10. Smalley WE, Ray WA, Daugherty J, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol. 1995;141:539–45.

    PubMed  CAS  Google Scholar 

  11. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med. 1988;109:359–63.

    PubMed  CAS  Google Scholar 

  12. Drummond MF. Basing prescription drug payment on economic analysis: the case of Australia. Health Aff (Millwood). 1992;11:191–6.

    Article  CAS  Google Scholar 

  13. Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Ann Intern Med. 1990;113:147–54.

    PubMed  CAS  Google Scholar 

  14. Walt RP. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. N Engl J Med. 1992;327:1575–80.

    Article  PubMed  CAS  Google Scholar 

  15. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan S. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991;325:87–91.

    Article  PubMed  CAS  Google Scholar 

  16. Gotzsche PC. Review of dose-response studies of NSAIDs in rheumatoid arthritis. Dan Med Bull. 1989;36:395–9.

    PubMed  CAS  Google Scholar 

  17. Kovar PA, Allegrante JP, MacKenzie R, Peterson MGE, Gutin B. Charlson ME. Supervised fitness walking in patients with osteoarthritis of the knee. Ann Intern Med. 1992;116:529–34.

    PubMed  CAS  Google Scholar 

  18. Deal CL, Schnitzer TJ, Lipstein E, Seibold JR, Stevens RM, Levy MD. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther. 1991;13:383–95.

    PubMed  CAS  Google Scholar 

  19. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. Ann Intern Med. 1992;116:535–9.

    PubMed  CAS  Google Scholar 

  20. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129:837–49.

    PubMed  CAS  Google Scholar 

  21. U.S. Department of Health and Human Services. The International Classification of Diseases, 9th Revision, Clinical Modification, ICD 9 CM. 2nd ed. Washington, DC: US Government Printing Office; 1980.

    Google Scholar 

  22. Latta VB, Helbing C. Medicare short-stay hospital services by diagnosis related groups. Health Care Financing Rev. 1991;12(4):105–25.

    CAS  Google Scholar 

  23. Kirshner CG, Burkett RC, Coy JA, et al. Physicians’ Current Procedural Terminology. 4th ed. Chicago, Ill: American Medical Association; 1993.

    Google Scholar 

  24. Drugs for rheumatoid arthritis. Med Lett Drugs Ther. 1993;33:65–70.

    Google Scholar 

  25. Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Stat. 1983;l:115–26.

    Article  Google Scholar 

  26. Kemper P. The use of formal and informal home care by the disabled elderly. Health Serv Res. 1992;27:421–49.

    PubMed  CAS  Google Scholar 

  27. McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. New York, NY: Chapman and Hall; 1989;193–208.

    Google Scholar 

  28. Kendall M, Stuart A. The Advanced Theory of Statistics. 4th ed. New York, NY:Macmillan; 1979;2:74.

    Google Scholar 

  29. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983;78:605–10.

    Article  Google Scholar 

  30. Wilcosky TC, Chambless LE. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J Chron Dis. 1985;38:849–56.

    Article  PubMed  CAS  Google Scholar 

  31. Manning WG, Newhouse JP, Duan N, Keeler EB. Leibowitz A, Marquis MS. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev. 1987;77:251–77.

    PubMed  CAS  Google Scholar 

  32. SAS Institute. The GLM procedure. In: SAS/STAT Users Guide, Version 6. Cary, NC: SAS Institute; 1989;890–996.

    Google Scholar 

  33. Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy: recognition and response. Arch Intern Med. 1989;147:2093–100.

    Article  Google Scholar 

  34. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991;115:787–96.

    PubMed  CAS  Google Scholar 

  35. Guess HA. West R. Stand LM. et al. Fatal upper gastrointestinal hemorrhage or perforation among users and non-users of non-steroidal anti-inflammatory drugs in Saskatchewan, Canada, 1983. J Clin Epidemiol. 1988;41:35–45.

    Article  PubMed  CAS  Google Scholar 

  36. Levy M, Miller DR, Kaufman DW, et al. Major upper gastrointestinal tract bleeding: relation to the use of aspirin and other nonnarcotic analgesics. Arch Intern Med. 1988;148:281–5.

    Article  PubMed  CAS  Google Scholar 

  37. Beard K, Walker AM, Perera DR, Jick H. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med. 1987;147:1621–3.

    Article  PubMed  CAS  Google Scholar 

  38. Langman MJS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and hemorrhage. BMJ. 1985;290:347–9.

    PubMed  CAS  Google Scholar 

  39. Campbell K, Steele RJC. Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study. Br J Surg. 1991;78:190–1.

    Article  PubMed  CAS  Google Scholar 

  40. Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving nonsteroidal anti-inflammatory drugs. Lancet. 1991;337:520.

    Article  PubMed  CAS  Google Scholar 

  41. Bjarnason I, Prouse P, Smith T, et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet. 1987;711–4.

  42. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications; 1983.

    Google Scholar 

  43. Bloom BS. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1989;149:1019–22.

    Article  PubMed  CAS  Google Scholar 

  44. Gabriel SE, Jaakkimainen RL, Bombardier C. The cost-effectiveness of misoprostol for nonsteroidal antinflammatory drug-associated adverse gastrointestinal events. Arthritis Rheum. 1993;36(4):447–59.

    Article  PubMed  CAS  Google Scholar 

  45. Edelson JT, Tosteson ANA, Sax P. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding. JAMA. 1990;264:41–7.

    Article  PubMed  CAS  Google Scholar 

  46. Hillman AL, Bloom BS. Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1989;149:2061–5.

    Article  PubMed  CAS  Google Scholar 

  47. Knill-Jones R, Drummond M, Kohli H. Davies L. Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs. Postgrad Med J. 1990;66:639–46.

    Article  PubMed  CAS  Google Scholar 

  48. Carrin GJ, Torfs KE. Economic evaluation of prophylactic treatment with misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium. Rev Epidemiol Sante Publique. 1990;38:187–99.

    PubMed  CAS  Google Scholar 

  49. de Pouvourville G. The economic consequences of NSAID-induced gastropathy: the French context. Scand J Rheumatol. 1992;96(suppl):49–53.

    Google Scholar 

  50. Stewart RB, Hale WE, Marks RG. Analgesic drug use in an ambulatory elderly population. Drug Intell Clin Pharmacol. 1982;16:833.

    CAS  Google Scholar 

  51. Graves EJ. Detailed diagnoses and procedures. National Hospital Discharge Survey, 1989. National Center for Health Statistics. Vital Health Stat. 1991;13:108.

    Google Scholar 

  52. McCarthy GM. McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol. 1992;19:604–7.

    PubMed  CAS  Google Scholar 

  53. Tomita DK, Kennedy DL, Baum C. Knapp DE. Anello C. Drug Utilization in the United States: 1988. Tenth Annual Review. Washington, DC: Department of Health and Human Services; 1989.

    Google Scholar 

  54. Tomita DK, Baum C, Kennedy DL, Knapp DE, Perry ZA. Drug Utilization in the United States: 1987. Ninth Annual Review. Washington, DC: Department of Health and Human Services; 1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. the Department of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, Tenn.

    Walter E. Smalley MD

  2. Division of General Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.

    Marie R. Griffin MD, MPH

  3. Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.

    Walter E. Smalley MD, Marie R. Griffin MD, MPH, Randy L. Fought BS & Wayne A. Ray PhD

Authors
  1. Walter E. Smalley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marie R. Griffin MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Randy L. Fought BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wayne A. Ray PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by a grant from the Agency for Health Care Policy Research (HS07768) and a cooperative agreement with the Food and Drug Administration (FD-U-0000073). Dr. Smalley was a Ciba-Geigy Fellow in Pharmacoepidemiology during the preparation of this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smalley, W.E., Griffin, M.R., Fought, R.L. et al. Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs. J Gen Intern Med 11, 461–469 (1996). https://doi.org/10.1007/BF02599040

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02599040

Keywords

Search

Navigation